The potential influence of fibromyalgia on disease activity assessment and baricitinib retention in rheumatoid arthritis
Rheumatology International · 10.11.2026 · 46 (12)
DOI: 10.1007/s00296-026-06347-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Rheumatology International, online erschienen am 10.11.2026. Verfasst von George Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Canberra Hospital, Yamba Drive, Garran, ACT, 2605, Canberra, Australia. georgechen2003@hotmail.com. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- The Canberra Hospital, Yamba Drive, Garran, ACT, 2605, Canberra, Australia. georgechen2003@hotmail.com.
- Jie Min Peng, Melbourne, Australia.
Zitieren
APA
Chen, G., & Peng, J. M. (2026). The potential influence of fibromyalgia on disease activity assessment and baricitinib retention in rheumatoid arthritis. Rheumatology International, 46(12). https://doi.org/10.1007/s00296-026-06347-2
Vancouver
Chen G, Peng JM. The potential influence of fibromyalgia on disease activity assessment and baricitinib retention in rheumatoid arthritis. Rheumatology International. 2026;46(12). doi:10.1007/s00296-026-06347-2
BibTeX
@article{Chen2026,
author = {Chen, George and Peng, Jie Min},
title = {The potential influence of fibromyalgia on disease activity assessment and baricitinib retention in rheumatoid arthritis},
journal = {Rheumatology International},
year = {2026},
volume = {46},
number = {12},
doi = {10.1007/s00296-026-06347-2}
}
EUVIMED